# FLUDEOXYGLUCOSE F-18

NDC: 78714-001
Generic name: FLUDEOXYGLUCOSE F-18
Labeler / Manufacturer: Barbara Ann Karmanos Cancer Hospital
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200131

FDA application: ANDA204385

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 300 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"78714-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=78714-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3791140-2e52-48c5-9849-536d5e4275e5